Abstract

Heterogeneous photocatalysis is a hot-spot research field for energy conversion and water detoxification. One of the most important challenges of photocatalysis is the designing and development of efficacious visible-light-triggered photocatalysts. In this regard, perovskite AgBiO3 and Ag/Bi elemental nanoparticles were decorated on brown TiO2−x via a facile procedure. Electron microscopy, XPS, and XRD studies provided strong evidence about developing TiO2−x/Ag/AgBiO3/Bi photocatalysts with quantum dot size of about 5.5 nm, and intimate contact among the counterparts. The TiO2−x/Ag/AgBiO3/Bi photocatalysts displayed boosted ability in the detoxification of tetracycline (TC), amoxicillin (AMX), fuchsine (FS), and methylene orange (MO) pollutants. The degradation rate constants of TC, AMX, FS, and MO over the optimum TiO2−x/Ag/AgBiO3/Bi photocatalyst were 25.9, 3.40, 5.70, and 1.92 folds greater than TiO2−x and 20.3, 12.3, 6.77, and 2.33 times larger than Ag/AgBiO3/Bi, respectively. Photoluminescence spectroscopy, EIS experiments, and Bode plots showed accelerated charge transfer and significant reduction of charges recombination within TiO2−x/Ag/AgBiO3/Bi nanocomposites. The recycling studies showed that the plasmonic photocatalyst retained the most activity after four times of utilization. Ultimately, an s-scheme charges segregation route was suggested for the boosted activity of the plasmonic TiO2−x/Ag/AgBiO3/Bi photocatalysts.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.